  |
 |
|
    |
|
|
|
|
      
|
|
NBA Agency Plan 2011
Organisation Chart
Contact index
Factsheet on the NBA
Bio Sheets on SES Officers
The NBA Board
The NBA GM:
Governance of the Blood Sector
National Blood Authority Act 2003
The National Blood Agreement
Financial Management and Accountability Act 1997
Where possible the relationship between operational information and specific functions, decision-making powers or recommendations that can be made by the NBA has been noted.
s 8(1)(a) – liaison and information gathering
s 8(1)(b) – annual plans and budgets for production and supply of blood products
s 8(1)(c) – carry out national blood arrangements to ensure sufficient supply nationally and s 8(1)(d) – carry out national blood arrangements relating to funding NBA operations and blood supply
s 8(1)(e) – enter and manage contracts to ensure sufficient supply
s 8(1)(f) – carry out national blood arrangements relating to safety, quality, contingency and risk mitigation measures for supply and s 8(1)(h) – carry out national bloodarrangements for facilitation and funding of research, policy development about relevant matters
25. (a)-(o) and Schedule 4 – applications
To meet current blood supply Needs
NBA Annual Reports since inception
Undertake national information gathering, monitoring of new developments, reporting and research in relation to the Australian Blood sector
NBA Annual Reports since inception
Details of our major contracts are listed on the Australian Government's AusTender site. A list of our Departmental and agency contracts for 2010-2011 can also be found at our ‘Departmental and agency contracts’ page of our website:
Grant reporting can be found at our ‘Grants’ page of our website:
The Legal Services Expenditure reports from 2006 onwards can be found at our ‘Legal Services Expenditure’ page of our website:
Information that can be published resulting from freedom of information requests and any routinely released information from such requests will be available on our Disclosure log page, which as at October 2011 is under-development.
At this stage the NBA has not identified any information routinely given through FOI access requests as very few requests are received by the Agency.
Information about our service charter and feedback arrangements can be found at our Customer Charter page. This page includes an interactive feedback form which can be used at any time to provide us with feedback on our services.
Customer Charter
In addition, we regularly put in place consultation arrangements for specific projects. Our current projects that include public consultation are included below:
Patient Blood Management Guideline Development – email registration for updates and consultation
You can contact the NBA about this IPS entry or obtain information about access to the NBA’s information or documents under the FOI Act via the details indicated.
Legal Counsel
| Ph: | 02 6211 8300 |
| email: | foi@nba.gov.au |
The Minister’s statement of expectation and the NBA Statement of Intent
The NBA Corporate Plan (2006-2009)
Pay and grading structures
Our 2011-12 portfolio budget statement can be found on the Department of Health and Ageing Budget webpage or the following link:
National Blood Authority (PDF 233 KB)
National Blood Authority (RTF 6.58 MB)
Other agency reports which are laid before Parliament and are relevant to the NBA will be included in this section.
Plasma Fractionation Review
Evidence-based clinical practice guidelines for the use of recombinant and plasma-derived FVIII and FIX products
Towards better, safer blood transfusion - A Report for the Australian Council for Safety and Quality in Health care
The following links and documents are located at various locations on our website. For ease of reference each of our factsheets, publications and education tools are listed here:
Red Cell Usage – UK audits on useage
Factsheet on Blood and Blood Products in Australia
Critical Bleeding/Massive Transfusion Guidelines
Criteria for the clinical use of intravenous immunoglobulin in Australia
Guidelines on the prophylactic use of Rh D immunoglobulin (anti-D) in obstetrics
NSW Clinical Excellence Commission
NSW Health Blood Watch
Queensland Blood Management Program
Queensland Health Patient Safety and Quality Improvement Service
Queensland Incidents in Transfusion (QiiT) Program
South Australian Department of Health BloodSafe Program
Victorian Blood Matters Better Safer Transfusion Program
Blood Matters Advisory Committee
International Haemovigilance Network
New Zealand Blood Service. Haemovigilance Program
Serious Hazards of Transfusion (SHOT) (UK)
Transfusion Transmitted Injuries Surveillance System (TTISS) (Canada).
Transfusion Quality Management (TRaQ) Program (Canada)
British Committee for Standards in Haematology
Annals of Internal Medicine
Current Issues in Transfusion Medicine
Journal of the American Medical Association
The Lancet
Leukaemia and Lymphoma Journal
Medical Journal of Australia
Network for Advancement of Transfusion Alternatives (NATA)
New England Journal of Medicine
Blood Matters
BloodSafe
BloodSafe documents
Blood Matters Transfusion Tools
Medicare Australia
National Health and Medical Research Council
Department of Health and Ageing
Clinical Excellence Commission (NSW)
Society for the Advancement of Blood Management (SABM)
Western Australia Patient Blood Management Program
Transfusion Audits
Australian and New Zealand Society of Blood Transfusion
Australian Association of Pathology Practices (AAPP)
Australian Commission on Safety and Quality in Health Care
Australian Council on Healthcare Standards
Australian Haemophilia Centre Directors' Organisation
Australian Institute of Medical Scientists
Australian Patient Safety Foundation
Australian Private Hospitals Association (APHA)
Australian Society of Clinical Immunology and Allergy
Australian Red Cross Blood Service
CSL Limited
Haematology Society of Australia and New Zealand (HSANZ)
Haemophilia Foundation Australia
NSW Clinical Excellence Commission
Queensland Health Patient Safety Centre
Royal Australasian College of Physicians
Royal Australasian College of Surgeons
SA Health - Safety and Quality
WA Health - Office of Safety and Quality in Healthcare
American Association of Blood Banks
American Society of Haematology (ASH)
British Blood Transfusion Society (BBTS)
Canadian Society of Transfusion Medicine (CSTM)
Centres for Disease Control and Prevention (CDC)
Council for International Organisation of Medical Sciences (CIOMS)
Food and Drug Administration (USA)
Haematology Society of Australia and New Zealand (HSANZ)
Haematology (by Cancer Network)
International Society of Blood Transfusion
International Society of Haematology (ISH)
International Standards Organisation (ISO)
IVIg in Neurological Disease Asia Pacific Symposium
UK Blood Transfusion & Tissue Transplantation Services
US Food and Drug Administration Centre for Biologics Evaluation and Research (FDA)
World Federation of Haemophilia
World Health Organisation (WHO)
UK NHSBT
Australian and New Zealand Society for Blood Transfusion
If you need assistance because the document or information on this website is not available in a format you can access please contact us for an alternative accessible format either via our Customer Feedback form at Customer Charter or via foi@nba.gov.au.
We invite you to provide comments on our Information Publication Scheme entry, particularly in relation to any documents that appear not to be discoverable, understandable or machine-readable. See our general contacts page for information on contacting us or send an email to iblood@nba.gov.au or foi@nba.gov.au.
Feedback | Privacy | Copyright | Disclaimer | Contact Us
This page last modified on November 11, 2011
| 
